The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abivax SA - ADR | SPONSORED ADS | 00370M103 | 55,289,441 | 414,899 | SH | SOLE | 414,899 | 0 | 0 | ||
| Achieve Life Sciences Inc. | Common | 004468500 | 17,964,239 | 2,751,032 | SH | SOLE | 2,751,032 | 0 | 0 | ||
| Aclaris Therapeutics, Inc. | Common | 00461U105 | 35,414,630 | 6,694,637 | SH | SOLE | 6,694,637 | 0 | 0 | ||
| Alto Neuroscience Inc | Common | 02157Q109 | 31,901,763 | 1,208,858 | SH | SOLE | 1,208,858 | 0 | 0 | ||
| ALX Oncology Holdings Inc | Common | 00166B105 | 6,592,356 | 3,184,713 | SH | SOLE | 3,184,713 | 0 | 0 | ||
| AN2 Therapeutics Inc | Common | 037326105 | 15,263,618 | 3,153,640 | SH | SOLE | 3,153,640 | 0 | 0 | ||
| Arrivent BioPharma Inc | Common | 04272N102 | 58,436,050 | 1,682,097 | SH | SOLE | 1,682,097 | 0 | 0 | ||
| Aura Biosciences Inc | Common | 05153U107 | 8,283,336 | 1,166,667 | SH | SOLE | 1,166,667 | 0 | 0 | ||
| Avalo Therapeutics Inc | Common | 05338F306 | 5,082,000 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| Bolt Biotherapeutics Inc | Common | 097702203 | 278,794 | 72,414 | SH | SOLE | 72,414 | 0 | 0 | ||
| Bright Minds Biosciences Inc | Common | 10919W405 | 39,113,474 | 557,172 | SH | SOLE | 557,172 | 0 | 0 | ||
| CAMP4 Therapeutics Corporation | Common | 13463J101 | 18,557,502 | 4,246,568 | SH | SOLE | 4,246,568 | 0 | 0 | ||
| Compass Therapeutics Inc | Common | 20454B104 | 16,987,961 | 7,757,060 | SH | SOLE | 7,757,060 | 0 | 0 | ||
| Corvus Pharmaceuticals Inc | Common | 221015100 | 41,918,891 | 2,805,816 | SH | SOLE | 2,805,816 | 0 | 0 | ||
| DBV Technologies SA | SPONSORED ADS | 23306J309 | 30,254,031 | 1,844,758 | SH | SOLE | 1,844,758 | 0 | 0 | ||
| Design Therapeutics Inc | Common | 25056L103 | 23,338,706 | 1,612,903 | SH | SOLE | 1,612,903 | 0 | 0 | ||
| Dianthus Therapeutics Inc | Common | 252828108 | 34,507,725 | 353,998 | SH | SOLE | 353,998 | 0 | 0 | ||
| Dyne Therapeutics Inc | Common | 26818M108 | 34,591,320 | 1,557,466 | SH | SOLE | 1,557,466 | 0 | 0 | ||
| Editas Medicine Inc | Common | 28106W103 | 11,519,010 | 3,555,250 | SH | SOLE | 3,555,250 | 0 | 0 | ||
| Erasca Inc | Common | 29479A108 | 75,614,188 | 4,127,412 | SH | SOLE | 4,127,412 | 0 | 0 | ||
| Eupraxia Pharmaceuticals Inc | Common | 29842P105 | 8,923,500 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
| Faeth Therapeutics Inc | Common | 81728A207 | 18,050,500 | 722,020 | SH | SOLE | 722,020 | 0 | 0 | ||
| Geron Corp | Common | 374163103 | 11,099,900 | 8,671,797 | SH | SOLE | 8,671,797 | 0 | 0 | ||
| InMed Pharmaceuticals Inc | Common | 457637700 | 1,237,484 | 798,377 | SH | SOLE | 798,377 | 0 | 0 | ||
| Instil Bio Inc | Common | 45783C200 | 2,251,194 | 292,743 | SH | SOLE | 292,743 | 0 | 0 | ||
| LB Pharmaceuticals Inc | Common | 50180M108 | 25,964,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| Minerva Neurosciences Inc | Common | 603380205 | 23,991,246 | 4,322,747 | SH | SOLE | 4,322,747 | 0 | 0 | ||
| Monopar Therapeutics Inc | Common | 61023L207 | 8,379,395 | 90,500 | SH | SOLE | 90,500 | 0 | 0 | ||
| Moonlake Immunotherapeutics | Class A ORD | 61559X104 | 27,258,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| Odyssey Therapeutics Inc | Common | 67613T104 | 10,758,250 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| Olema Pharmaceuticals Inc | Common | 68062P106 | 8,404,756 | 671,843 | SH | SOLE | 671,843 | 0 | 0 | ||
| Onkure Therapeutics Inc | Common | 68277Q105 | 8,790,358 | 1,927,710 | SH | SOLE | 1,927,710 | 0 | 0 | ||
| Oric Pharmaceuticals Inc | Common | 68622P109 | 20,022,352 | 1,848,786 | SH | SOLE | 1,848,786 | 0 | 0 | ||
| Pasithea Therapeutics Corp | Common | 70261F202 | 239,904 | 465,471 | SH | SOLE | 465,471 | 0 | 0 | ||
| Pepgen Inc | Common | 713317105 | 4,185,000 | 2,325,000 | SH | SOLE | 2,325,000 | 0 | 0 | ||
| Praxis Precision Medicines | Common | 74006W207 | 90,766,926 | 271,116 | SH | SOLE | 271,116 | 0 | 0 | ||
| Precision Biosciences Inc | Common | 74019P207 | 36,746 | 4,675 | SH | SOLE | 4,675 | 0 | 0 | ||
| SAB Biotherapeutics Inc | Common | 78397T202 | 28,469,645 | 7,299,909 | SH | SOLE | 7,299,909 | 0 | 0 | ||
| Satellos Bioscience Inc | Common | 80401L803 | 6,326,253 | 813,666 | SH | SOLE | 813,666 | 0 | 0 | ||
| Sera Prognostics Inc | Common | 81749D107 | 3,003,801 | 1,650,440 | SH | SOLE | 1,650,440 | 0 | 0 | ||
| Sinovac Biotech Ltd. | SHS | P8696W104 | 38,192,410 | 5,903,000 | SH | SOLE | 5,903,000 | 0 | 0 | ||
| Surrozen Inc | Common | 86889P208 | 6,747,000 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| Tango Therapeutics Inc | Common | 87583X109 | 43,131,579 | 1,379,769 | SH | SOLE | 1,379,769 | 0 | 0 | ||
| Tenax Therapeutics Inc | Common | 88032L605 | 36,375,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| Trevi Therapeutics Inc | Common | 89532M101 | 95,015,558 | 5,094,668 | SH | SOLE | 5,094,668 | 0 | 0 | ||
| Unicycive Therapeutics | Common | 90466Y202 | 2,579,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| Valneva SE | SPONSORED ADS | 92025Y103 | 3,991,531 | 763,199 | SH | SOLE | 763,199 | 0 | 0 | ||